The First Australian BRCA-P Participants Share Their Stories
Cousins Raylee and Lisa are the first Australian participants in the ground-breaking BRCA-P clinical trial.
The BRCA-P trial is a prevention trial which is testing the effectiveness of a drug called Denosumab in preventing breast cancer in women with a BRCA1 gene mutation, like Lisa and Raylee. This treatment has been fast-tracked from the lab to a stage three clinical trial due to its impressive pre-clinical results.
Listen in as Lisa and Raylee tell us what it's like to know you have a 70% risk of being diagnosed with breast cancer due to the BRCA1 gene mutation, their experiences in participating in the BRCA-P clinical trial, and what their children think about their 50/50 chance of having the BRCA1 gene mutation.
Like this episode? Follow Breast Cancer Trials on Social Media:
- Instagram: @breastcancertrials
- Facebook: Breast Cancer Trials
- LinkedIn: Breast Cancer Trials
- X: @BCTrialsANZ
Guests: Raylee and Lisa, the first Australian participants in the ground-breaking BRCA-P clinical trial.
Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.
Find out more: www.breastcancertrials.org.au